[1]Abayomi J,Kirwan J，Hackett A,et al.A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer［J］.Human Nutrit Diet,2005,18(5)：353-363.
[2]Pang XZ,Sun WW,Wang SQ.Prevention on uterine cervix cancer patients accepting radiotherapy complicated with radiation proctitis［J］.Journal of Chinese Nursing Res,2008,22(8):2203-2204.［庞秀枝，孙维维，王淑琴.宫颈癌放射治疗并发放射性肠炎的预防［J］.护理研究，2008,22(8):2203-2204.］
[3]Li L.The curative effect of deproteinised calf blood serum injection combined with Kangfuxin liquid in treating acute radiation proctopathy［J］.Modern Oncology,2014,22(11):2671-2673.［李梁.小牛血清去蛋白注射液联合康复新治疗急性放射性直肠炎的疗效分析［J］.现代肿瘤医学，2014,22(11):2671-2673.］
[4]Zhao WY,Zhang LZ，Zhao HF,et al.Effect of compound glutamine entero-souble capsule on prevention of acute radiation proctitis［J］.Modern Oncology，2013,21(4):808-810.［张维勇，张丽珍，赵滑峰，等.复方谷氨酰胺防治急性放射性直肠炎临床研究［J］.现代肿瘤医学，2013，21(4):808-810.］
[5]Dong J,Zhao XX,Shu J.Efficacy of TCM retention enema on prevention in cervical cancer patients radiation proctitis［J］.Modern Oncology,2012,20(7):1421-1423.［董晶，赵西侠，舒瑾.中药保留灌肠预防宫颈癌放射性直肠炎的临床观察［J］.现代肿瘤医学，2012,20(7):1421-1423.］
[6]Jiang YQ，Zhong H，Li M,et al.Clinical observation on the application of montmorillonite with Kangfuxinye retention enema for prevention of acute radiation proctitis［J］.Chinese Clinical Oncology,2015，20(10):933-936.［江英强，钟惠，黎明，等.蒙脱石散联合康复新液保留灌肠预防放射性直肠炎的临床观察［J］.中国肿瘤学杂志，2015，20(10):933-936.］
[7]Wang YG,Qin L,Dou YQ.Efficacy observation of daihuang shaoyao san in the treatment of radiation proctitis in the rats［J］.World Journal of Integrated Traditional and Western Medicine,2016,11(7):934-937.［王毓国，秦丽，窦永起.黛黄芍药散对大鼠放射性直肠炎的疗效观察［J］.世界中西医结合杂志,2016，11(7):934-937.］
[8]Northover J，Glynne-Jones R，Sebag-Montefiore D，et al.Chemoradiation for the treatment of epidermoid anal cancer：13-year follow-up of the first randomised UKCCCR Anal Cancer Trial(ACT I) ［J］.Br J Cancer,2010,102:1123-1128.
[9]Cathy E，James A，Bruce DM.Chemotherapy and radiation of anal canal cancer：The first approach［J］.Surg Oncol Clin N Am,2004，13：309-320.
[10]Bledsoe TJ,Noble AR,Rddy CA,et al.Split-course accelerated hypofractionated radiatherapy(SCAHRT)：A safe and effective option for head and neck cancer in the elderly or infirm［J］.Anticancer Res，2016，36(3):933-939.
[11]Miszcyk L,Maciejewski B,Tukiendorf A,et al.Split-course accelerted hyperfractionated irradiation(CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trial［J］.Br Jradiol，2014,87(1041):4012-4018.
[12]Dandekar VK,Young J,Kiel K,et al.Efficacy and tolerability of palliative split-course thoracic chermoradiotherapy for symptomatic non-small cell lung cancer［J］.Am J Clin Oncol,2015,38(6):605-609.
[13]Fukuda M,Nakamura Y,Kinoshita A,et al.Phase Ⅱ study of irinotecan and ciplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer［J］.Cancer Chemother Phamacol，2012,70(5):645-651.
[14]Kancherla KN,Oksuz DC，Prestwich RJ,et al.The roleof split-course hypofractionated palliative radiotherapy in head and neck cancer［J］.Clin Oncol，2011,23(2):141-148.
[15]Yin WB,Yu ZH,Xu GZ,et al.Radiation Oncology［M］.Beijing：Peking Union Medical College Press,2008:251-259.［殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学［M］.北京：中国协和医科大学出版社，2008：251-259.］